Troy A. Ignelzi - 10 May 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Issuer symbol
N/A
Transactions as of
10 May 2021
Net transactions value
-$728,250
Form type
4
Filing time
12 May 2021, 17:28:50 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $64,400 +7,000 +54% $9.20* 20,000 10 May 2021 Direct
transaction KRTX Common Stock Sale $770,490 -7,000 -35% $110.07 13,000 10 May 2021 Direct F1
transaction KRTX Common Stock Options Exercise $1,840 +200 +1.5% $9.20* 13,200 12 May 2021 Direct
transaction KRTX Common Stock Sale $24,000 -200 -1.5% $120.00 13,000 12 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -7,000 -3.5% $0.000000 194,925 10 May 2021 Common Stock 7,000 $9.20 Direct
transaction KRTX Option (right to buy) Options Exercise $0 -200 -0.1% $0.000000 194,725 12 May 2021 Common Stock 200 $9.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.